CH311609A - Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). - Google Patents

Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).

Info

Publication number
CH311609A
CH311609A CH311609DA CH311609A CH 311609 A CH311609 A CH 311609A CH 311609D A CH311609D A CH 311609DA CH 311609 A CH311609 A CH 311609A
Authority
CH
Switzerland
Prior art keywords
anilide
methyl
propylamine
chloro
new
Prior art date
Application number
Other languages
German (de)
Inventor
Aktiengesellschaft Cilag
Original Assignee
Cilag Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilag Ag filed Critical Cilag Ag
Publication of CH311609A publication Critical patent/CH311609A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Description

  

  



  Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure    (2-balogen-6-methyl-anilids).   



   Gegenstand des vorliegenden Patentes bildet ein Verfahren zur Herstellung eines neuen   basiseli substituierten Fettsäure- (2-halogen-6-    methyl-anilids), welches dadurch gekennzeichnet ist, dass man eine Verbindung der Formel
EMI1.1     
 in weleher X einen reaktionsfahigen, während der Reaktion sich   abspaltenden    Rest bedeutet, mit n-Propylamin umsetzt.



   Der Rest X kann in einem Halogenatom oder einem sonstigen f r den Austausch gegen den basischen Rest geeigneten reaktionsfähigen Substituenten, wie z. B. einer Alkylsulfonyloxy-oder   Arylsulfonyloxygruppe, beste-    hen. Der Austausch der Gruppe X gegen den   n-Propylaminrest erfolgt    z. B. durch einfaches Erwärmen mit n-Propylamin gegebenenfalls in Gegenwart eines basisch reagierenden Kon  densationsmittels oder    von n-Propylamin im ¯berschu¯. Das   n-Propylaminoacet- (2-chlor-6-      methyl-anilid)    ist ein farbloses, unter 0,   02    mm Hg bei 147-150  siedendes   il.    Das Hydroehlorid der Base schmilzt bei 253-257 .



   Das neue Anilid soll als   Lokalanästhetikum    und als Zwischenprodukt zur Herstellung weiterer Derivate Verwendung finden.



   Beispiel :
40 Gewichtsteile Chloracet-(2-chlor-6-me  thyl-anilid)    (gewonnen durch Umsetzen von 2-Chlor-6-methyl-anilin mit Chloracetylchlorid in Gegenwart von Natriumacetat, Schmp. 140 bis   141 )    werden in 90 Gewichtsteilen ¯thanol , suspendiert und mit 50   Gewiehtsteilen    n-Pro  pylamin    versetzt. Die Temperatur steigt dabei leicht an und ein grosser Teil des Rea. ktionsgemisehes geht in   Losung.    Nun wird wä. hrend 4 Stunden bei Zimmertemperatur gerührt und dann einige Stunden bei   65-75 .    Eine Probe mit Wasser und nachfolgend mit verdünnter Salzsäure versetzt ergibt wieder Lösung des ausgefallenen Niederschlages.

   Mit Wasserda. mpf wird hierauf der Alkohol und das   über-      schüssige    n-Propyla. min abgeblasen und nach dem Erkalten das zurückbleibende   (il    in Äther aufgenommen. Nach dem Trocknen der   ätheri-    schen   Losung    und   Verjagen    des   Losungsmit-    tels verbleibt ein   61,    das durch   Vakuum-    destillation gereinigt wird. Man erhält 40 Gewichtsteile reines n-Propyl-aminoacet-(2-chlor6-methyl-anilid). Die Umsetzung mit n-Propylamin kann auch in Benzol stattfinden.  



   PATENTANSPRUCH :
Verfahren zur Herstellung eines neuen basiseh   substituierten Fettsäure-(2-halogen6-      methyl-anilids),    dadurch gekennzeichnet, dass man eine Verbindung der Formel 

**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.





  



  Process for the production of a new basic substituted fatty acid (2-balogen-6-methyl-anilide).



   The subject of the present patent is a process for the preparation of a new basiseli substituted fatty acid (2-halogen-6-methyl-anilide), which is characterized in that a compound of the formula
EMI1.1
 in which X is a reactive radical which is split off during the reaction and reacts with n-propylamine.



   The radical X can be in a halogen atom or another reactive substituent suitable for replacement with the basic radical, such as e.g. B. an alkylsulfonyloxy or arylsulfonyloxy group exist. The exchange of group X against the n-propylamine radical takes place, for. B. by simply heating with n-propylamine, optionally in the presence of a basic reacting condensation agent or n-propylamine in excess. The n-propylaminoacet- (2-chloro-6-methyl-anilide) is a colorless, below 0.02 mm Hg at 147-150 boiling. The hydrochloride of the base melts at 253-257.



   The new anilide is to be used as a local anesthetic and as an intermediate product for the production of further derivatives.



   Example:
40 parts by weight of chloroacet- (2-chloro-6-methyl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroacetyl chloride in the presence of sodium acetate, melting point 140 to 141) are dissolved in 90 parts by weight of ethanol, suspended and mixed with 50 parts by weight of n-propylamine. The temperature rises slightly and a large part of the rea. ctionsgemisehes goes into solution. Now wä. Stirred for 4 hours at room temperature and then for a few hours at 65-75. A sample with water and then mixed with dilute hydrochloric acid results in a solution of the precipitate.

   With Wasserda. The alcohol and the excess n-propyla then become mpf. min.blown off and after cooling the remaining (il taken up in ether. After drying the ethereal solution and driving off the solvent, a 61 remains, which is purified by vacuum distillation. 40 parts by weight of pure n-propyl-aminoacetate are obtained - (2-chloro-6-methyl-anilide) The reaction with n-propylamine can also take place in benzene.



   PATENT CLAIM:
Process for the preparation of a new baseeh-substituted fatty acid (2-halogen6-methyl-anilide), characterized in that a compound of the formula

** WARNING ** End of DESC field could overlap beginning of CLMS **.



 

Claims (1)

**WARNUNG** Anfang CLMS Feld konnte Ende DESC uberlappen **. ** WARNING ** Beginning of CLMS field could overlap end of DESC **. Verfahren zur Herstellung eines neuen basisch substituierten Fettsäure (2-balogen-6-methyl-anilids). Process for the production of a new basic substituted fatty acid (2-balogen-6-methyl-anilide). Gegenstand des vorliegenden Patentes bildet ein Verfahren zur Herstellung eines neuen basiseli substituierten Fettsäure- (2-halogen-6- methyl-anilids), welches dadurch gekennzeichnet ist, dass man eine Verbindung der Formel EMI1.1 in weleher X einen reaktionsfahigen, während der Reaktion sich abspaltenden Rest bedeutet, mit n-Propylamin umsetzt. The subject of the present patent is a process for the preparation of a new basiseli substituted fatty acid (2-halogen-6-methyl-anilide), which is characterized in that a compound of the formula EMI1.1 in which X is a reactive radical which is split off during the reaction and reacts with n-propylamine. Der Rest X kann in einem Halogenatom oder einem sonstigen f r den Austausch gegen den basischen Rest geeigneten reaktionsfähigen Substituenten, wie z. B. einer Alkylsulfonyloxy-oder Arylsulfonyloxygruppe, beste- hen. Der Austausch der Gruppe X gegen den n-Propylaminrest erfolgt z. B. durch einfaches Erwärmen mit n-Propylamin gegebenenfalls in Gegenwart eines basisch reagierenden Kon densationsmittels oder von n-Propylamin im ¯berschu¯. Das n-Propylaminoacet- (2-chlor-6- methyl-anilid) ist ein farbloses, unter 0, 02 mm Hg bei 147-150 siedendes il. Das Hydroehlorid der Base schmilzt bei 253-257 . The radical X can be in a halogen atom or another reactive substituent suitable for replacement with the basic radical, such as e.g. B. an alkylsulfonyloxy or arylsulfonyloxy group exist. The exchange of group X against the n-propylamine radical takes place, for. B. by simply heating with n-propylamine, optionally in the presence of a basic reacting condensation agent or n-propylamine in excess. The n-propylaminoacet- (2-chloro-6-methyl-anilide) is a colorless, below 0.02 mm Hg at 147-150 boiling. The hydrochloride of the base melts at 253-257. Das neue Anilid soll als Lokalanästhetikum und als Zwischenprodukt zur Herstellung weiterer Derivate Verwendung finden. The new anilide is to be used as a local anesthetic and as an intermediate product for the production of further derivatives. Beispiel : 40 Gewichtsteile Chloracet-(2-chlor-6-me thyl-anilid) (gewonnen durch Umsetzen von 2-Chlor-6-methyl-anilin mit Chloracetylchlorid in Gegenwart von Natriumacetat, Schmp. 140 bis 141 ) werden in 90 Gewichtsteilen ¯thanol , suspendiert und mit 50 Gewiehtsteilen n-Pro pylamin versetzt. Die Temperatur steigt dabei leicht an und ein grosser Teil des Rea. ktionsgemisehes geht in Losung. Nun wird wä. hrend 4 Stunden bei Zimmertemperatur gerührt und dann einige Stunden bei 65-75 . Eine Probe mit Wasser und nachfolgend mit verdünnter Salzsäure versetzt ergibt wieder Lösung des ausgefallenen Niederschlages. Example: 40 parts by weight of chloroacet- (2-chloro-6-methyl-anilide) (obtained by reacting 2-chloro-6-methyl-aniline with chloroacetyl chloride in the presence of sodium acetate, melting point 140 to 141) are dissolved in 90 parts by weight of ethanol, suspended and mixed with 50 parts by weight of n-propylamine. The temperature rises slightly and a large part of the rea. ctionsgemisehes goes into solution. Now wä. Stirred for 4 hours at room temperature and then for a few hours at 65-75. A sample with water and then mixed with dilute hydrochloric acid results in a solution of the precipitate. Mit Wasserda. mpf wird hierauf der Alkohol und das über- schüssige n-Propyla. min abgeblasen und nach dem Erkalten das zurückbleibende (il in Äther aufgenommen. Nach dem Trocknen der ätheri- schen Losung und Verjagen des Losungsmit- tels verbleibt ein 61, das durch Vakuum- destillation gereinigt wird. Man erhält 40 Gewichtsteile reines n-Propyl-aminoacet-(2-chlor6-methyl-anilid). Die Umsetzung mit n-Propylamin kann auch in Benzol stattfinden. With Wasserda. The alcohol and the excess n-propyla then become mpf. min.blown off and after cooling the remaining (il taken up in ether. After drying the ethereal solution and driving off the solvent, a 61 remains, which is purified by vacuum distillation. 40 parts by weight of pure n-propyl-aminoacetate are obtained - (2-chloro-6-methyl-anilide) The reaction with n-propylamine can also take place in benzene. PATENTANSPRUCH : Verfahren zur Herstellung eines neuen basiseh substituierten Fettsäure-(2-halogen6- methyl-anilids), dadurch gekennzeichnet, dass man eine Verbindung der Formel EMI2.1 in welcher X einen reaktionsfähigen, während der Reaktion sich abspaltenden Rest bedeutet, mit n-Propylamin umsetzt. Das auf diese Weise erhaltene n-Propyl-aminoacet- (2-chlor6-methyl-anilid) bildet ein fa. rbloses, unter 0, 02 mon Hg bei 147-150"siedendes Öl. Das Hydrochlorid der Base sehmilzt bei 253-257". PATENT CLAIM: Process for the preparation of a new baseeh-substituted fatty acid (2-halogen6-methyl-anilide), characterized in that a compound of the formula EMI2.1 in which X is a reactive radical which is split off during the reaction, reacts with n-propylamine. The n-propyl-aminoacet- (2-chloro-6-methyl-anilide) obtained in this way forms a fa. Unbeless oil boiling below 0.02 mon Hg at 147-150 ". The hydrochloride of the base melts at 253-257". Das neue Anilid soll als Lokalanästhet. ikum und als Zwischenprodukt Verwendung finden. The new anilide is said to be used as a local anesthetic. ikum and as an intermediate use. UNTERANSPBUCH : Verfahren nac-h Patentansprueh, dadureh gekennzeichnet, dass man ein Halogenacet- (2 chlor-6-methyl-a. nilid) mit n-Propylamin re- agieren lϯt. SUB-CLAIM: Process according to patent claim, characterized in that a haloacet- (2 chloro-6-methyl-a. Nilide) is allowed to react with n-propylamine.
CH311609D 1952-02-25 1952-02-25 Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide). CH311609A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH311609T 1952-02-25
CH307799T 1952-11-25

Publications (1)

Publication Number Publication Date
CH311609A true CH311609A (en) 1955-11-30

Family

ID=25735342

Family Applications (1)

Application Number Title Priority Date Filing Date
CH311609D CH311609A (en) 1952-02-25 1952-02-25 Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).

Country Status (1)

Country Link
CH (1) CH311609A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10842798B1 (en) 2019-11-06 2020-11-24 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10968179B2 (en) 2019-03-11 2021-04-06 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11643404B2 (en) 2019-03-11 2023-05-09 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US11603355B2 (en) 2019-03-11 2023-03-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10968179B2 (en) 2019-03-11 2021-04-06 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11512058B2 (en) 2019-03-11 2022-11-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10842798B1 (en) 2019-11-06 2020-11-24 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11696912B2 (en) 2019-11-06 2023-07-11 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Similar Documents

Publication Publication Date Title
CH311609A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311606A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311613A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311610A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311608A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311607A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311614A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311612A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311615A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311611A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311629A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311604A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311603A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311630A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311605A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311619A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311616A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311642A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311621A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311632A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311631A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311639A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311620A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH311644A (en) Process for the production of a new basic substituted fatty acid (2-halogen-6-methyl-anilide).
CH312572A (en) Process for the preparation of a new basic substituted fatty acid (2-halo-6-methyl) anilide